Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Decreases By 31.6%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) saw a significant drop in short interest in February. As of February 28th, there was short interest totalling 2,600 shares, a drop of 31.6% from the February 13th total of 3,800 shares. Based on an average daily volume of 65,900 shares, the days-to-cover ratio is currently 0.0 days.

NLS Pharmaceutics Stock Performance

NLSPW stock opened at $0.01 on Tuesday. NLS Pharmaceutics has a twelve month low of $0.01 and a twelve month high of $0.09. The stock’s 50 day moving average is $0.01 and its 200-day moving average is $0.01.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).